A CNIO research team discovers new regulators of the most prevalent liver disease

CNIO researchers, in collaboration with Johan Auwerx from the EPFL in Lausanne, have discovered novel factors, the AP-1 proteins, which are critically involved in fatty liver disease pathogenesis. These results are featured on the cover of the latest issue of Cell Metabolism, the leading journal in the field of metabolism. Read more